The drug Eliquis was recently withdrawn from the market after being linked to a significant number of deaths. Lawsuits are now beginning, and it’s not yet clear what middlemen may be liable for injuries caused by the medication.
Eliquis is a blood thinner that has been linked to serious side effects. The lawsuit investigation will help determine whether or not the drug was mislabeled and if it should continue being prescribed. Read more in detail here: eliquis settlement amounts.
Overview: New Blood is Thinner, but the Problems Remain the Same
Pfizer and Bristol-Meyers Squibb launched Eliquis (apixaban) in 2012 to prevent stroke in individuals with atrial fibrillation and blood clots in patients having hip or knee replacement surgery. After Pradaxa and Xarelto, it is the third member of a new generation of blood thinners that were brought to the market to compete with warfarin, which has been the main blood thinner recommended by physicians for decades.
Pradaxa, Xarelto, and now Eliquis have all been actively pushed and touted as better alternatives to warfarin (Coumadin), which needs a careful diet and frequent blood tests. However, based on the number of adverse events reported to the FDA, these new blood thinners are among the most hazardous medicines to take.
Uncontrollable internal bleeding and hemorrhage are the most frequent side effects reported by consumers. Pradaxa, Xarelto, and Eliquis, unlike warfarin, do not have an antidote to halt internal bleeding if it occurs. Hundreds of individuals have had uncontrolled bleeding, necessitating hospitalization and, in extreme cases, death.
Thousands of product liability lawsuits have been filed against the makers of Pradaxa, Xarelto, and Eliquis, claiming that they created and marketed a hazardous medication and neglected to notify consumers or the medical community that there is no reversal agent.
Lawsuits involving Eliquis
Eliquis (apixaban) is a relatively new anticoagulant, yet it has previously been the subject of legal action due to its potentially fatal bleeding hazards. As cases against the makers of Pradaxa and Xarelto proceed, lawyers are bracing for an inflow of Eliquis claims against Pfizer and Bristol-Meyers Squibb.
Pradaxa’s maker, Boehringer Ingelheim, is presently facing over 2,000 Pradaxa lawsuits. In May 2014, the drugmaker agreed to pay $650 million to resolve almost 4,000 Pradaxa claims, with each case costing an average of $150,000.
Xarelto’s makers, Bayer and Johnson & Johnson, are also facing lawsuits over allegations that they neglected to warn consumers about the drug’s bleeding dangers. Nearly 50 federal Xarelto cases were consolidated in the Eastern District of Louisiana by the United States Judicial Panel on Multidistrict Litigation in December 2014. In the first few months of 2015, many more Xarelto cases are likely to be filed.
Drug companies are also accused of carelessly producing and marketing Eliquis without properly communicating the drug’s danger of uncontrolled bleeding, according to Eliquis lawsuits. Plaintiffs in the Eliquis case are demanding damages for medical costs, anguish and suffering, and other losses.
Get a Free Eliquis Lawsuit Analysis
Patients are filing lawsuits against Eliquis all across the nation right now. Family members of patients who died as a result of Eliquis side effects are now filing wrongful death claims. The Eliquis attorneys at Top Class Actions want to hear from you if you or someone you know was harmed while using this blood thinner.
Fill out the form on this page right now to get a free case assessment to determine whether you qualify to file an Eliquis lawsuit or participate in an Eliquis class action investigation.
The “eliquis horror stories” is a lawsuit filed by the family of a woman who died after taking Eliquis. The lawsuit claims that there are many side effects to this drug.
Frequently Asked Questions
Is there a class action lawsuit against Eliquis?
A: There is no class action lawsuit against Eliquis.
Is Eliquis Black Box Warning?
A: Eliquis (apixaban) is black boxed for the following uses: acute coronary syndrome, thrombolytic therapy.
Are there any recalls on Eliquis?
A: Currently, there are no recalls on Eliquis.
- eliquis lawsuit 2021
- eliquis class action lawsuit
- the truth about eliquis
- eliquis complaints
- eliquis recall 2020